Can Aspirin Cause Heartburn and How to Prevent It

Aspirin is one of the most common causes of drug-related heartburn, stomach pain, and other upper gastrointestinal symptoms. The drug irritates the digestive tract through two separate pathways: direct contact damage to the lining of the stomach and esophagus, and a body-wide suppression of the protective chemicals that keep that lining intact. The good news is that several strategies, from simple timing adjustments to specific medications, can reduce the burn without forcing you to give up aspirin’s well-established heart benefits.

How Aspirin Irritates the Digestive Tract

Aspirin belongs to the broader family of non-steroidal anti-inflammatory drugs (NSAIDs), all of which share a tendency to upset the stomach. But aspirin has a double mechanism that makes it especially harsh on the gut. First, it causes direct physical damage wherever it touches the lining. Early microscopy work showed that when aspirin particles sit against the stomach wall, they strip away surface cells and cause structural damage to the acid-producing cells underneath, eventually leading to small erosions.¹

Second, aspirin blocks an enzyme that produces prostaglandins, the chemicals your stomach relies on to maintain its protective mucus layer and regulate acid secretion. Without enough prostaglandins, the stomach’s defenses thin out, leaving the tissue vulnerable to its own acid.² This systemic effect matters because it means the damage is not limited to wherever the pill happens to dissolve. Even after a single standard-dose aspirin tablet, enzyme activity in the stomach lining can remain suppressed by more than half for at least three days.³

The heartburn you feel after taking aspirin is essentially acid reaching tissue that no longer has its usual protection. In some people this stays mild, a dull burning behind the breastbone or a sour taste. In others it progresses to genuine inflammation of the esophagus or stomach ulcers. Aspirin has also been documented to cause direct esophageal lesions if a tablet lodges on the way down, particularly in people who swallow pills without enough water or who lie down right after.⁴

Who Is at Higher Risk

Not everyone who takes aspirin gets heartburn or develops stomach problems. Several factors tilt the odds. Age is probably the biggest: the older you are, the thinner your stomach’s protective barrier tends to be, and the less efficiently your body repairs everyday wear. A history of peptic ulcers or gastrointestinal bleeding is another strong predictor, as is infection with the bacterium H. pylori, which independently damages the stomach lining and multiplies aspirin’s effect.⁵

Dose plays a role, though the relationship is not as straightforward as you might expect. Observational data show a clear dose-dependent rise in bleeding risk: one large case-control study found that the relative risk roughly doubled at 100 mg daily, rose to about six times at 300 mg daily, and exceeded ten times at 1,000 mg daily.⁶ However, when researchers compared low-dose ranges head to head in randomized trials, the differences between 75 mg and 325 mg were not statistically significant. The practical takeaway is that any dose of aspirin carries some gastrointestinal risk, and higher doses amplify it.

What you take alongside aspirin matters just as much. Combining low-dose aspirin with other NSAIDs like ibuprofen roughly triples the risk of upper gastrointestinal bleeding. Adding blood thinners or high-dose corticosteroids pushes it even higher: one study found that high-dose oral corticosteroids combined with low-dose aspirin increased bleeding risk more than fourfold.⁷ The combination of aspirin with anticoagulants or corticosteroids, or even just a second NSAID, consistently produces excess bleeding risk beyond what either drug alone would cause.⁸

The Enteric Coating Myth

Enteric-coated aspirin is marketed as being gentler on the stomach. The idea is simple: a special shell prevents the tablet from dissolving until it passes through the stomach and reaches the small intestine. In theory, this avoids the direct contact damage to the stomach lining. In controlled seven-day trials comparing low-dose enteric-coated aspirin to plain aspirin in healthy volunteers, the coated version did cause fewer visible lesions on endoscopy.⁹

But this short-term endoscopy finding has not translated into real-world protection. A systematic review of epidemiological studies found that aspirin was associated with upper gastrointestinal complications even when used in buffered or enteric-coated formulations.¹⁰ A separate systematic review focused specifically on enteric-coated aspirin concluded that the coating was not an effective mechanism for gastrointestinal protection overall, and that patients taking it in a large trial actually reported more heartburn-like symptoms including reflux and upper abdominal discomfort.¹¹ A large Dutch cohort study comparing self-reported gastrointestinal symptoms between users of plain and enteric-coated aspirin found no meaningful difference.¹²

The reason is the dual mechanism described earlier. Even if the coating prevents local contact damage in the stomach, the systemic prostaglandin suppression still happens once the drug is absorbed from the intestine. The coating shifts where aspirin dissolves, but it does not change what aspirin does to your body’s protective chemistry. If you switched to enteric-coated aspirin hoping to stop your heartburn, you may be disappointed.

Medications That Actually Help

The most effective pharmacological approach for preventing aspirin-related heartburn and more serious gastrointestinal complications is adding an acid-suppressing drug. Proton pump inhibitors (PPIs) like omeprazole, lansoprazole, and esomeprazole are the most studied option. A meta-analysis of trials found that PPIs reduced the risk of low-dose aspirin-associated ulcers by about 84% and the risk of bleeding by about 73% compared with placebo or no treatment.¹³ PPIs work by shutting down the acid pumps in the stomach wall, which dramatically lowers the amount of acid available to damage weakened tissue.¹⁴

If PPIs are not a good fit, H2-receptor blockers like famotidine offer a lighter-touch alternative. A randomized, placebo-controlled trial found that famotidine given alongside low-dose aspirin cut the rate of gastric ulcers from 15% to about 3%, duodenal ulcers from roughly 9% to under 1%, and erosive esophagitis from 19% to about 4% over 12 weeks.¹⁵ Famotidine is available over the counter in most countries and is generally well tolerated, making it a practical option if your main complaint is heartburn rather than a documented ulcer.

Clinical guidelines for high-risk patients, meaning those with multiple risk factors or those taking aspirin alongside corticosteroids, anticoagulants, or other NSAIDs, generally recommend co-prescribing a PPI or, where PPIs are contraindicated, adding a protective agent like misoprostol.¹⁶ If you are on long-term low-dose aspirin and experiencing regular heartburn, asking your doctor about adding one of these medications is the single most evidence-backed thing you can do.

Newer Formulations Worth Knowing About

Since enteric coating has proved disappointing for real-world gastrointestinal protection, researchers have explored other ways to reformulate aspirin. The most promising involves wrapping aspirin molecules in phospholipids, the same type of fat molecules that make up cell membranes. The idea came from early animal studies showing that when aspirin was chemically associated with phosphatidylcholine, gastric erosions dropped dramatically compared with plain aspirin, even though the drug still suppressed prostaglandin production to the same degree.¹⁷ In human trials, the phospholipid-aspirin complex showed fewer erosions and appeared to be absorbed more reliably than enteric-coated tablets.¹⁸

This formulation (marketed in some countries as PL-ASA) addresses the local contact injury problem differently from enteric coating. Instead of moving dissolution downstream, it envelops the aspirin in a lipid layer that physically shields the stomach lining during dissolution. It is not yet widely available everywhere and costs more than generic aspirin, but it represents the direction the field is moving: protecting the stomach locally while leaving aspirin’s systemic effects untouched.

Practical Steps to Reduce Heartburn From Aspirin

Not every solution requires a prescription. Several habits can reduce the odds of aspirin-related heartburn or at least lessen the severity when it occurs:

Take it with food: Eating something before or with your aspirin dilutes the drug’s concentration against the stomach wall and slows absorption, which blunts the initial local irritation.
Drink a full glass of water: Swallowing aspirin with too little liquid increases the chance the tablet will stick to the esophagus, causing direct chemical burns. Remaining upright for at least 30 minutes after taking it also helps.
Avoid alcohol around dosing: Alcohol independently irritates the stomach lining and increases acid production, compounding aspirin’s effects.
Use the lowest effective dose: If your aspirin is for cardiovascular prevention, the typical recommended dose is 75 to 100 mg. Taking more than prescribed does not add heart protection but does add gastrointestinal risk.
Do not combine with other NSAIDs casually: Reaching for ibuprofen or naproxen on top of daily aspirin is one of the fastest ways to run into trouble. If you need additional pain relief, talk to your doctor about alternatives that do not stack NSAID risk.

These measures are not guaranteed to eliminate symptoms, especially if you have other risk factors. But they cost nothing and reduce exposure to the two damage pathways discussed earlier.

When Symptoms Do Not Match Damage

One of the more unsettling aspects of aspirin’s gastrointestinal effects is how poorly symptoms correlate with what is actually happening inside. Research has consistently shown that the absence of heartburn or stomach pain does not mean the stomach lining is fine. Endoscopic studies have found that the presence or absence of symptoms has little predictive value for the severity of mucosal damage.¹⁹ Some people develop significant erosions or ulcers with no discomfort at all, while others have intense burning with only mild surface irritation.

This disconnect runs in both directions. Focus group research found that almost half of people taking low-dose aspirin who experienced upper gastrointestinal symptoms blamed the symptoms on lifestyle factors like stress or spicy food, rather than considering their medication as the cause.²⁰ The implication is twofold: if you are on daily aspirin and you have new or worsening heartburn, consider the aspirin as a possible cause rather than dismissing it. And if you have no symptoms at all but carry several risk factors (age over 65, history of ulcers, concurrent use of blood thinners), a conversation with your doctor about protective medication is still warranted.

Why You Should Not Just Stop Taking Aspirin

If aspirin is causing you misery, the instinct to simply stop taking it is understandable. But if you are on long-term low-dose aspirin for cardiovascular prevention, quitting abruptly is genuinely dangerous. A large Swedish population-based study found that people who discontinued low-dose aspirin outside the context of major surgery or a bleeding event had a greater than 30% increased risk of cardiovascular events compared with those who continued.²¹ A UK primary care study found an even sharper signal: people who recently stopped aspirin had a roughly 60% higher risk of non-fatal heart attack compared with current users.²²

The risk is especially stark in people who have already had a cardiovascular event. One study following patients who stopped aspirin after a peptic ulcer bleed found a more than sixfold increase in death or acute cardiovascular events within the first six months, though this elevated risk was concentrated among those who had cardiovascular disease at baseline.²³ The message is clear: managing aspirin’s gastrointestinal side effects is far safer than stopping the drug on your own. If your heartburn is severe enough that you are considering quitting, bring that to your doctor, who can add a protective medication, adjust your dose, or explore alternatives.

How Aspirin Compares With Other Antiplatelet Drugs

If aspirin’s stomach effects are a recurring problem, you might wonder whether switching to a different blood-thinning medication would help. The most commonly compared alternative for cardiovascular prevention is clopidogrel. In the large CAPRIE trial, which randomized thousands of patients at risk of blood-clot-related events to either clopidogrel or aspirin, the rate of upper gastrointestinal discomfort was about 1.2% in the aspirin group compared with about 1.0% in the clopidogrel group, and gastrointestinal bleeding occurred in roughly 0.7% of aspirin users versus 0.5% of clopidogrel users.²⁴ Clopidogrel does appear slightly gentler on the gut, but the difference is modest rather than dramatic, and the drug is substantially more expensive and not always interchangeable for every indication.

Clopidogrel also has its own gastrointestinal considerations. It does not suppress prostaglandins the way aspirin does, so it avoids that particular pathway, but it can still impair healing of existing ulcers because it reduces blood flow to the stomach lining through its antiplatelet effect. In practice, guidelines reserve the switch to clopidogrel for patients who truly cannot tolerate aspirin even with gastroprotective therapy, rather than as a routine first-line swap for heartburn symptoms.

Testing for H. pylori Before Long-Term Use

One underappreciated prevention strategy is checking for H. pylori infection before starting long-term aspirin. This bacterium, which lives in the stomach lining of roughly half the world’s population, independently increases the risk of ulcers. When aspirin’s prostaglandin-suppressing effect is layered on top of an active H. pylori infection, the two risk factors multiply rather than simply add up.⁵ Eradicating the infection with a short course of antibiotics before beginning aspirin therapy can substantially lower the baseline ulcer risk, giving the stomach a much better starting position. A simple breath test or stool antigen test can identify the infection, and treatment typically takes one to two weeks. Despite this, many people start long-term aspirin without ever being tested. If you are about to begin daily aspirin and have never been screened for H. pylori, it is worth raising with your doctor.